Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31Holding companyfalse32024-01-01false2falsefalse 07890595 2024-01-01 2024-12-31 07890595 2023-01-01 2023-12-31 07890595 2024-12-31 07890595 2023-12-31 07890595 2023-01-01 07890595 c:Director1 2024-01-01 2024-12-31 07890595 c:Director3 2024-01-01 2024-12-31 07890595 c:RegisteredOffice 2024-01-01 2024-12-31 07890595 d:CurrentFinancialInstruments 2024-12-31 07890595 d:CurrentFinancialInstruments 2023-12-31 07890595 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 07890595 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 07890595 d:UKTax 2024-01-01 2024-12-31 07890595 d:UKTax 2023-01-01 2023-12-31 07890595 d:ShareCapital 2024-01-01 2024-12-31 07890595 d:ShareCapital 2024-12-31 07890595 d:ShareCapital 2023-01-01 2023-12-31 07890595 d:ShareCapital 2023-12-31 07890595 d:ShareCapital 2023-01-01 07890595 d:CapitalRedemptionReserve 2024-01-01 2024-12-31 07890595 d:CapitalRedemptionReserve 2024-12-31 07890595 d:CapitalRedemptionReserve 2023-01-01 2023-12-31 07890595 d:CapitalRedemptionReserve 2023-12-31 07890595 d:CapitalRedemptionReserve 2023-01-01 07890595 d:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 07890595 d:RetainedEarningsAccumulatedLosses 2024-12-31 07890595 d:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 07890595 d:RetainedEarningsAccumulatedLosses 2023-12-31 07890595 d:RetainedEarningsAccumulatedLosses 2023-01-01 07890595 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2024-12-31 07890595 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2023-12-31 07890595 c:OrdinaryShareClass1 2024-01-01 2024-12-31 07890595 c:OrdinaryShareClass1 2024-12-31 07890595 c:OrdinaryShareClass1 2023-12-31 07890595 c:OrdinaryShareClass2 2024-01-01 2024-12-31 07890595 c:OrdinaryShareClass2 2024-12-31 07890595 c:OrdinaryShareClass2 2023-12-31 07890595 c:OrdinaryShareClass3 2024-01-01 2024-12-31 07890595 c:OrdinaryShareClass3 2024-12-31 07890595 c:OrdinaryShareClass3 2023-12-31 07890595 c:OrdinaryShareClass4 2024-01-01 2024-12-31 07890595 c:OrdinaryShareClass4 2024-12-31 07890595 c:OrdinaryShareClass4 2023-12-31 07890595 c:FRS102 2024-01-01 2024-12-31 07890595 c:Audited 2024-01-01 2024-12-31 07890595 c:FullAccounts 2024-01-01 2024-12-31 07890595 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07890595 d:Subsidiary1 2024-01-01 2024-12-31 07890595 d:Subsidiary1 1 2024-01-01 2024-12-31 07890595 6 2024-01-01 2024-12-31 07890595 e:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number:  07890595














MDS CEM HOLDINGS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


 
MDS CEM HOLDINGS LIMITED
 
 
COMPANY INFORMATION


Directors
S Hamon (appointed 14 January 2025) 
David Nyland 




Registered number
07890595



Registered office
Suite 423 Chadwick House
Birchwood Park

Birchwood

Warrington

Cheshire

WA3 6AE




Independent auditors
Langtons Professional Services Limited
Chartered Accountants & Statutory Auditors

100 Old Hall Street

Liverpool

L3 9QJ





 
MDS CEM HOLDINGS LIMITED
 

CONTENTS



Page
Strategic report
1
Directors' report
2 - 3
Independent auditors' report
4 - 7
Statement of comprehensive income
8
Statement of financial position
9
Statement of changes in equity
10
Analysis of net debt
11
Notes to the financial statements
12 - 20


 
MDS CEM HOLDINGS LIMITED
 
 
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

Introduction
 
The directors present their strategic report for the year ended 31 December 2024.

Business review
 
The Directors aim to present a balanced and comprehensive review of the development and performance of the business during the year, and its position at the year-end. Our review is consistent with the size and noncomplex nature of the business and is written in the context of the risks and uncertainties we face.

Principal risks and uncertainties
 
The Company’s principal investment is MDS Global Ltd and therefore its principal risks are those facing MDS Global which are as follows:
Competition: MDS Global provides Business Support Systems (BSS) in a highly competitive global market. This requires MDS Global to continuously innovate and be highly responsive to market demands. MDS Global mitigates this risk by investing in marketing, strategic partnerships, solution strategy, design and technology. This ensures MDS Global remains a leading provider of BSS, offering high quality solutions and services which are scalable, cost effective, flexible and relevant into the future. The international teams are committed to long-term, collaborative relationships, providing thought leadership and sharing best practices to help customers succeed.
Security: Like most businesses cyber threats pose a risk to MDS Global. MDS Global recognises the potential impact of a security breach for the business in terms of reputational damage but also the detrimental ramifications for the customer. MDS Global therefore invests in both technology and internal controls to ensure the infrastructure remains secure.
People: MDS Global recognises the importance of people to facilitate the continued growth profile of the business. The business maximises staff retention by investing in training programmes and proactively promoting career development.
Political: The UK exit from the European Union in January 2020, presents a continued level of political uncertainty. As with other businesses in the UK, MDS Global is also impacted by changes to government policies such as the recent increases in employer National Insurance contributions and recent inflationary pressures. We have considered the implications for its investment in MDS Global and have concluded it is unlikely to have any material adverse impact on the business.

Financial key performance indicators
 
The Company’s main income source is derived from its investment in MDS Global Ltd. The directors use the Key Performance Indicators defined by our parent group to manage its investment in MDS Global and these Key Performance Indicators are noted in the financial statements of MDS Global Limited.


This report was approved by the board on 24 September 2025 and signed on its behalf.



Sophie Hamon
Director

Page 1

 
MDS CEM HOLDINGS LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The directors present their report and the financial statements for the year ended 31 December 2024.

Directors' responsibilities statement

The directors are responsible for preparing the Strategic report, the Directors' report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the Company's financial statements and then apply them consistently;

make judgments and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Results and dividends

The profit for the year, after taxation, amounted to £3,999,938 (2023 - £12,208).

Dividends of £4,000,000 were paid during the year. The directors do not propose any further dividends for the year.

Director

The director who served during the year was:

David Nyland 

Future developments

The Company continues to look for further investment opportunities.

Page 2

 
MDS CEM HOLDINGS LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

Disclosure of information to auditors

Each of the persons who are directors at the time when this Directors' report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company's auditors are unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

Post balance sheet events

There have been no significant events affecting the Company since the year end.

Auditors

The auditorsLangtons Professional Services Limitedwill be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

This report was approved by the board on 24 September 2025 and signed on its behalf.
 





Sophie Hamon
Director

Page 3

 
MDS CEM HOLDINGS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF MDS CEM HOLDINGS LIMITED
 

Opinion

We have audited the financial statements of MDS CEM Holdings Limited (the 'Company') for the year ended 31 December 2024, which comprise the Statement of comprehensive income, the Statement of financial position, the Statement of changes in equity and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the Company's affairs as at 31 December 2024 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' report thereon. The directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Page 4

 
MDS CEM HOLDINGS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF MDS CEM HOLDINGS LIMITED (CONTINUED)


Opinion on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic report and the Directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Strategic report and the Directors' report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic report or the Directors' report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Directors' responsibilities statement set out on page 2, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.

Page 5

 
MDS CEM HOLDINGS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF MDS CEM HOLDINGS LIMITED (CONTINUED)


Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud
The objectives of our audit, in respect to fraud, are:
•  to identify and assess the risks of material misstatement of the financial statements due to fraud;
•  to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due
 to fraud, through designing and implementing appropriate responses; and
•  to respond appropriately to fraud or suspected fraud identified during the audit.
However, the primary responsibility for the prevention and detection of fraud rests with both those charged with governance of the entity and management.
Our approach was as follows:
We obtained an understanding of the legal and regulatory frameworks that are applicable to the Company and determined that the most significant are those that relate to the reporting framework (FRS 102 and the Companies Act 2006), the relevant tax compliance regulations in the UK and the EU General Data Protection Regulation (GDPR).
We understood how the Company is complying with those frameworks by making enquiries of management. Through consideration of the results of our audit procedures we were able to either corroborate or provide contrary evidence which was then followed up.
Based on our understanding we designed our audit procedures to identify non-compliance with laws and regulations. Our procedures involved:
•  enquiries of management; and
•  journal entry testing, with a focus on journals indicating large or unusual transactions based on our
 understanding of the business.
We assessed the susceptibility of the Company’s financial statements to material misstatement, including how fraud might occur by meeting with management to understand where it considered there was susceptibility to fraud. We also considered performance targets and their propensity to influence efforts made by management to manage revenue and earnings. Where the risk was considered to be higher, including areas impacting key performance indicators or management remuneration, we performed audit procedures to address each identified fraud risk or other risk of material misstatement. These procedures included those on revenue recognition detailed above, the assessment of items identified by management as non-recurring and testing manual journals and were designed to provide reasonable assurance that the financial statements were free from material fraud or error.

Page 6

 
MDS CEM HOLDINGS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF MDS CEM HOLDINGS LIMITED (CONTINUED)


A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' report.

Use of our report

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.




Eifion Roberts (Senior statutory auditor)
  
for and on behalf of
Langtons Professional Services Limited
 
Chartered Accountants
Statutory Auditors
  
100 Old Hall Street
Liverpool
L3 9QJ

24 September 2025
Page 7

 
MDS CEM HOLDINGS LIMITED
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024

2024
2023
Note
£
£

  

Administrative expenses
  
(62)
15,962

Operating (loss)/profit
 3 
(62)
15,962

Income from shares in group undertakings
  
4,000,000
-

Profit before tax
  
3,999,938
15,962

Tax on profit
 6 
-
(3,754)

Profit for the financial year
  
3,999,938
12,208

There were no recognised gains and losses for 2024 or 2023 other than those included in the statement of comprehensive income.

There was no other comprehensive income for 2024 (2023:£NIL).

The notes on pages 12 to 20 form part of these financial statements.

Page 8

 
MDS CEM HOLDINGS LIMITED
REGISTERED NUMBER: 07890595

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 8 
18,669,134
18,669,134

  
18,669,134
18,669,134

Current assets
  

Debtors: amounts falling due within one year
 9 
7,251,000
4,251,000

Cash at bank and in hand
 10 
458
274

  
7,251,458
4,251,274

Creditors: amounts falling due within one year
 11 
(8,991,271)
(5,991,025)

Net current liabilities
  
 
 
(1,739,813)
 
 
(1,739,751)

Total assets less current liabilities
  
16,929,321
16,929,383

  

Net assets
  
16,929,321
16,929,383


Capital and reserves
  

Called up share capital 
 13 
5,304,758
5,304,758

Capital redemption reserve
 14 
319,752
319,752

Profit and loss account
 14 
11,304,811
11,304,873

  
16,929,321
16,929,383


The financial statements were approved and authorised for issue by the board and were signed on its behalf on 24 September 2025.




Sophie Hamon
Director

The notes on pages 12 to 20 form part of these financial statements.

Page 9

 
MDS CEM HOLDINGS LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024


Called up share capital
Capital redemption reserve
Profit and loss account
Total equity

£
£
£
£


At 1 January 2023
5,304,758
319,752
11,292,665
16,917,175


Comprehensive income for the year

Profit for the year
-
-
12,208
12,208
Total comprehensive income for the year
-
-
12,208
12,208



At 1 January 2024
5,304,758
319,752
11,304,873
16,929,383


Comprehensive income for the year

Profit for the year
-
-
3,999,938
3,999,938
Total comprehensive income for the year
-
-
3,999,938
3,999,938


Contributions by and distributions to owners

Dividends: Equity capital
-
-
(4,000,000)
(4,000,000)


At 31 December 2024
5,304,758
319,752
11,304,811
16,929,321


The notes on pages 12 to 20 form part of these financial statements.

Page 10

 
MDS CEM HOLDINGS LIMITED
 

ANALYSIS OF NET DEBT
FOR THE YEAR ENDED 31 DECEMBER 2024




At 1 January 2024
Cash flows
At 31 December 2024
£

£

£

Cash at bank and in hand

274

184

458


274
184
458

The notes on pages 12 to 20 form part of these financial statements.

Page 11

 
MDS CEM HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

MDS CEM Holdings Limited is a private limited company incorporated and registered in England and Wales. Its registered office is Suite 423 Chadwick House, Birchwood Park, Birchwood, Warrington, Cheshire, WA3 6AE. The company number is 07890595.
The principal activity of the company is a holding company to companies engaged in the provision of software and managed services for Communication Service Providers in the Telecommunications Industry. The companies provide Cloud solutions for convergent real time charging, billing and customer management.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The presentation currency of these financial statements is pound sterling; the financial statements are rounded to the nearest pound

The following principal accounting policies have been applied:

  
2.2

Exemption from preparing consolidated financial statements

The Company is a parent Company that is also a subsidiary included in the consolidated financial statements of its ultimate parent undertaking established under the law of a non-EEA state and is therefore exempt from the requirement to prepare consolidated financial statements under section 401 of the Companies Act 2006.

 
2.3

Going concern

The Company remains profitable and meets its day to day working capital requirements through its own cash funds.
The company’s forecasts and projections, taking account of reasonably possible changes in trading performance, show that the company should be able to operate within the level of its current cash resources.
After making enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus, the directors continue to adopt the going concern basis in preparing the annual report and financial statements.

Page 12

 
MDS CEM HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.4

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.6

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 13

 
MDS CEM HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Statement of financial position when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Impairment of financial assets

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. 
Page 14

 
MDS CEM HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.10
Financial instruments (continued)


Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Other financial instruments

Derivatives, including forward exchange contracts, futures contracts and interest rate swaps, are not classified as basic financial instruments. These are initially recognised at fair value on the date the derivative contract is entered into, with costs being charged to the profit or loss. They are subsequently measured at fair value with changes in the profit or loss.

Debt instruments that do not meet the conditions as set out in FRS 102 paragraph 11.9 are subsequently measured at fair value through the profit or loss. This recognition and measurement would also apply to financial instruments where the performance is evaluated on a fair value basis as with a documented risk management or investment strategy.

 
2.11

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 15

 
MDS CEM HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

3.


Operating (loss)/profit

The operating (loss)/profit is stated after charging:

2024
2023
£
£

Exchange differences
-
(15,996)


4.


Auditors' remuneration

During the year, the Company obtained the following services from the Company's auditors:


2024
2023
£
£

Fees payable to the Company's auditors for the audit of the Company's financial statements
1,500
1,500


5.


Employees




The average monthly number of employees, including the directors, during the year was as follows:


        2024
        2023
            No.
            No.







Directors
2
3


6.


Taxation


2024
2023
£
£

Corporation tax


Current tax on profits for the year
-
3,754


Total current tax
-
3,754
Page 16

 
MDS CEM HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
 
6.Taxation (continued)


Factors affecting tax charge for the year

The tax assessed for the year is the same as (2023 - the same as) the standard rate of corporation tax in the UK of 25% (2023 - 23.52%) as set out below:

2024
2023
£
£


Profit on ordinary activities before tax
3,999,938
15,962


Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2023 - 23.52%)
999,985
3,754

Effects of:


Dividends from UK companies
(1,000,000)
-

Unrelieved tax losses carried forward
15
-

Total tax charge for the year
-
3,754


Factors that may affect future tax charges

There were no factors that may affect future tax charges.


7.


Dividends

2024
2023
£
£


Dividends paid
4,000,000
-

4,000,000
-

Page 17

 
MDS CEM HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

8.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2024
18,669,134



At 31 December 2024
18,669,134





Subsidiary undertaking


The following was a subsidiary undertaking of the Company:

Name

Registered office

Class of shares

Holding

MDS Global Limited
Suite 423, Chadwick House, Birchwood Park, Birchwood, Warrington, Cheshire, WA3 6AE
Ordinary
100%


9.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
7,251,000
4,251,000

7,251,000
4,251,000



10.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
458
274

458
274


Page 18

 
MDS CEM HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

11.


Creditors: Amounts falling due within one year

2024
2023
£
£

Amounts owed to group undertakings
8,928,670
5,924,670

Corporation tax
62,601
66,355

8,991,271
5,991,025



12.


Financial instruments

2024
2023
£
£

Financial assets


Financial assets measured at fair value through profit or loss
458
274




Financial assets measured at fair value through profit or loss comprise cash at bank and in hand.


13.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



757,540 (2023 - 757,540) Ordinary shares of £7.00 each
5,302,780
5,302,780
21,500 (2023 - 21,500) A1 shares of £0.02 each
430
430
7,098 (2023 - 7,098) A2 shares of £0.02 each
142
142
70,315 (2023 - 70,315) Deferred shares of £0.02 each
1,406
1,406

5,304,758

5,304,758



14.


Reserves

Capital redemption reserve

Represents the nominal value of shares repurchased by the company.

Profit and loss account

The profit and loss account represents the total of all profits and losses made to date, less dividends paid.

Page 19

 
MDS CEM HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

15.


Related party transactions

The company has taken advantage of the exemption under paragraph 33.1A of FRS 102 and has not disclosed transactions with other wholly owned group companies.


16.


Controlling party

The immediate parent undertaking is Velocix Solutions Limited, a company registered in England and Wales.
The ultimate parent undertaking is Lumine Group Inc. a company incorporated in Canada.
Copies of the consolidated financial statements of  Lumine Group Inc. are publicly available from 5060 Spectrum Way, Suite 100, Mississauga, ON L4W 5N5, Canada.

 
Page 20